COPLAND ROAD CAPITAL NEW (A2P) - Total Liabilities
Based on the latest financial reports, COPLAND ROAD CAPITAL NEW (A2P) has total liabilities worth €347.02 Million EUR (≈ $405.71 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
COPLAND ROAD CAPITAL NEW - Total Liabilities Trend (2022–2025)
This chart illustrates how COPLAND ROAD CAPITAL NEW's total liabilities have evolved over time, based on quarterly financial data. See working capital position of COPLAND ROAD CAPITAL NEW to evaluate short-term liquidity relative to the company's equity base.
COPLAND ROAD CAPITAL NEW Competitors by Total Liabilities
The table below lists competitors of COPLAND ROAD CAPITAL NEW ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Civista Bancshares Inc
NASDAQ:CIVB
|
USA | $3.79 Billion |
|
Bright Minds Biosciences Inc
NASDAQ:DRUG
|
USA | $3.83 Million |
|
Smartgen (Zhengzhou) Technology Co. Ltd. A
SHE:301361
|
China | CN¥59.73 Million |
|
Shenzhen Riland Industry Co
SHE:300154
|
China | CN¥923.44 Million |
|
Sella Real Estate
TA:SLARL
|
Israel | ILA3.40 Billion |
|
Bank Bukopin Tbk
JK:BBKP
|
Indonesia | Rp78.54 Trillion |
|
Zhejiang Reclaim Construction Group Co Ltd
SHE:002586
|
China | CN¥3.60 Billion |
|
Cheryong Electric Co.Ltd
KQ:033100
|
Korea | ₩32.93 Billion |
Liability Composition Analysis (2022–2025)
This chart breaks down COPLAND ROAD CAPITAL NEW's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of COPLAND ROAD CAPITAL NEW.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.57 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how COPLAND ROAD CAPITAL NEW's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for COPLAND ROAD CAPITAL NEW (2022–2025)
The table below shows the annual total liabilities of COPLAND ROAD CAPITAL NEW from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €265.57 Million ≈ $310.48 Million |
+43.37% |
| 2024-12-31 | €185.23 Million ≈ $216.56 Million |
+11.78% |
| 2023-12-31 | €165.71 Million ≈ $193.74 Million |
+11.49% |
| 2022-12-31 | €148.63 Million ≈ $173.77 Million |
-- |
About COPLAND ROAD CAPITAL NEW
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics … Read more